Triple Antibiotic (Melaleuca, Inc.)


Welcome to the PulseAid listing for the Triple Antibiotic drug offered from Melaleuca, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Melaleuca, Inc.
NON-PROPRIETARY NAME: Bacitracin zinc and Neomycin and Polymyxin B sulfate
SUBSTANCE NAME: BACITRACIN ZINC; NEOMYCIN; POLYMYXIN B SULFATE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: OINTMENT
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 1995-07-01
END MARKETING DATE: 0000-00-00


Triple Antibiotic HUMAN OTC DRUG Details:

Item DescriptionTriple Antibiotic from Melaleuca, Inc.
LABELER NAME: Melaleuca, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500; 3.5; 10000([iU]/g; mg/g; [iU]/g)
START MARKETING DATE: 1995-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54473-578_91649003-07b6-4620-a513-dcd1edc3ae32
PRODUCT NDC: 54473-578
APPLICATION NUMBER: part333B

Other BACITRACIN ZINC; NEOMYCIN; POLYMYXIN B SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Budpak Inc.Triple Antibiotic
Melaleuca, Inc.Triple Antibiotic